Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Raj

Showing results (271-280 of 306) with videos related to

Pageof 31
Sort By:
Molecular Cell|September 6, 2016
Non-Cell-Autonomous Regulation of Prostate Epithelial Homeostasis by Androgen ReceptorBoyu Zhang, Oh-Joon Kwon, Gervaise Henry, et al.
Nature Communications|November 30, 2016
Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancerChristine Henzler, Yingming Li, Rendong Yang, et al.
Elife|August 9, 2017
Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancersGanesh V Raj, Gangadhara Reddy Sareddy, Shihong Ma, et al.
Breast Cancer Research : BCR|December 28, 2019
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancersSuryavathi Viswanadhapalli, Shihong Ma, Gangadhara Reddy Sareddy, et al.
International Journal of Radiation Oncology, Biology, Physics|November 14, 2021
SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation TrialRaquibul Hannan, Samer Salamekh, Neil B Desai, et al.
Cancer Research|December 4, 2018
IFNγ-Induced IFIT5 Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer via miRNA ProcessingU-Ging Lo, Rey-Chen Pong, Diane Yang, et al.
Oncotarget|November 12, 2015
Expression of androgen receptor splice variants in clinical breast cancersTheresa E Hickey, Connie M Irvine, Heidi Dvinge, et al.
The Journal of Clinical Investigation|April 29, 2020
The landscape of RNA polymerase II-associated chromatin interactions in prostate cancerSusmita G Ramanand, Yong Chen, Jiapei Yuan, et al.
Molecular Oncology|August 18, 2018
A patient-derived explant (PDE) model of hormone-dependent cancerMargaret M Centenera, Theresa E Hickey, Shalini Jindal, et al.
Science Translational Medicine|June 8, 2012
A validated tumorgraft model reveals activity of dovitinib against renal cell carcinomaSharanya Sivanand, Samuel Peña-Llopis, Hong Zhao, et al.
Pageof 31

Showing results (271-280 of 306) with videos related to

Sort By:
Pageof 31
Molecular Cell|September 6, 2016
Non-Cell-Autonomous Regulation of Prostate Epithelial Homeostasis by Androgen ReceptorBoyu Zhang, Oh-Joon Kwon, Gervaise Henry, et al.
Nature Communications|November 30, 2016
Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancerChristine Henzler, Yingming Li, Rendong Yang, et al.
Elife|August 9, 2017
Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancersGanesh V Raj, Gangadhara Reddy Sareddy, Shihong Ma, et al.
Breast Cancer Research : BCR|December 28, 2019
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancersSuryavathi Viswanadhapalli, Shihong Ma, Gangadhara Reddy Sareddy, et al.
International Journal of Radiation Oncology, Biology, Physics|November 14, 2021
SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation TrialRaquibul Hannan, Samer Salamekh, Neil B Desai, et al.
Cancer Research|December 4, 2018
IFNγ-Induced IFIT5 Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer via miRNA ProcessingU-Ging Lo, Rey-Chen Pong, Diane Yang, et al.
Oncotarget|November 12, 2015
Expression of androgen receptor splice variants in clinical breast cancersTheresa E Hickey, Connie M Irvine, Heidi Dvinge, et al.
The Journal of Clinical Investigation|April 29, 2020
The landscape of RNA polymerase II-associated chromatin interactions in prostate cancerSusmita G Ramanand, Yong Chen, Jiapei Yuan, et al.
Molecular Oncology|August 18, 2018
A patient-derived explant (PDE) model of hormone-dependent cancerMargaret M Centenera, Theresa E Hickey, Shalini Jindal, et al.
Science Translational Medicine|June 8, 2012
A validated tumorgraft model reveals activity of dovitinib against renal cell carcinomaSharanya Sivanand, Samuel Peña-Llopis, Hong Zhao, et al.
Pageof 31